Light at the end of the tunnel of antibiotic development.
作者信息
Tillotson Glenn S
机构信息
TranScrip Partners LLC, Downingtown, PA 19335, USA.
出版信息
Lancet Infect Dis. 2013 Dec;13(12):1008-9. doi: 10.1016/S1473-3099(13)70316-5. Epub 2013 Nov 17.
Abstract
摘要
相似文献
1
Light at the end of the tunnel of antibiotic development.
Lancet Infect Dis. 2013 Dec;13(12):1008-9. doi: 10.1016/S1473-3099(13)70316-5. Epub 2013 Nov 17.
2
Antibiotic resistance in Ghana.
Lancet Infect Dis. 2013 Dec;13(12):1006-7. doi: 10.1016/S1473-3099(13)70196-8. Epub 2013 Nov 17.
3
Antibiotic resistance: global response needed.
Lancet Infect Dis. 2013 Dec;13(12):1001-3. doi: 10.1016/S1473-3099(13)70195-6. Epub 2013 Nov 17.
4
Antibiotic resistance needs global solutions.
Lancet Infect Dis. 2014 Jul;14(7):549-50. doi: 10.1016/S1473-3099(14)70800-X.
5
Antibiotic resistance needs global solutions.
Lancet Infect Dis. 2014 Jul;14(7):549. doi: 10.1016/S1473-3099(14)70799-6.
6
Antibiotic resistance needs global solutions.
Lancet Infect Dis. 2014 Jul;14(7):550. doi: 10.1016/S1473-3099(14)70801-1.
7
Antibiotic effectiveness and child survival.
Lancet Infect Dis. 2013 Dec;13(12):1004-5. doi: 10.1016/S1473-3099(13)70317-7. Epub 2013 Nov 17.
8
Antibiotic resistance: long-term solutions require action now.
Lancet Infect Dis. 2013 Dec;13(12):995. doi: 10.1016/S1473-3099(13)70290-1. Epub 2013 Nov 17.
9
[The microbial threat 4. Elements of a sensible antibiotic policy: utilization without development of resistance].
Ugeskr Laeger. 1998 Oct 26;160(44):6340-2.
10
Global collaboration to encourage prudent antibiotic use.
Lancet Infect Dis. 2013 Dec;13(12):1003-4. doi: 10.1016/S1473-3099(13)70315-3. Epub 2013 Nov 17.
Zotero 插件